NCT06680050 2025-12-18
AUSTRAL
Mario Negri Institute for Pharmacological Research
Phase 2 Recruiting
Clinical Trials
3 trialsNCT07188480 2025-09-23
The Role of DNA and RNA in NGS Analyses for Advaced Stage NSCLC Patients
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Phase NA Recruiting
NCT07087223 2025-07-25
Phase Ib/II Study of Vebreltinib With Furmonertinib in NSCLC Patients With c-Met Amplification After EGFR-TKI Failure
Peking University Cancer Hospital & Institute
Phase 1/2 Recruiting